Advertisement

Balchem Corporation BCPC

Set alert

Price alert · BCPC

All alert types
169.98 USD -0.42 -0.25%

At close · Oct 30

169.98 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
169.97 × 2
Ask
170.08 × 2
169.77 Day range 172.89
147.36 52-week range 183.26
YTD
+10.84%
1 year
+10.40%
Open
172.89
Prev close
170.40
Mkt cap
5.42B
Vol
249.29K
Avg vol
231.98K
EPS
5.30
P/E
32.07
Div yield
0.56%
More statistics
Low
169.77
High
172.89
Forward P/E
26.71
Beta
0.85
Short ratio
2.04
Inst. own
93.81%
Dividend
0.96
Ex-div date
Dec 22, 2025
Earnings
Feb 19, 2027
50-d avg
170.36
200-d avg
169.21
1y target
213.50

3M chart

Chart tools
Interval

Events in this range
  • Jul 31, 2026Earnings: 1.4; estimate 1.27; surprise 10.24%
  • Aug 3, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 23, 2026Earnings: 1.57; estimate 1.43; surprise 9.79%
  • Oct 23, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (21)
NameDateAgo
SMA: BearishOct 30, 20262 days ago
SMA: BullishOct 29, 20263 days ago
SMA: BullishOct 29, 20263 days ago
SMA: BearishOct 28, 20264 days ago
MACD: Sell SignalOct 28, 20264 days ago
SMA: BearishOct 26, 20266 days ago
SMA: BullishOct 22, 20261 week ago
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BullishOct 12, 20262 weeks ago
MACD: Buy SignalOct 7, 20263 weeks ago
MACD: Sell SignalSep 30, 20261 month ago
MACD: Buy SignalSep 25, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BearishSep 3, 20261 month ago
SMA: BullishSep 2, 20262 months ago
SMA: BearishSep 1, 20262 months ago
MACD: Sell SignalAug 24, 20262 months ago
RSI: OverboughtAug 5, 20262 months ago
SMA: BullishJul 31, 20263 months ago
SMA: BullishJul 31, 20263 months ago

Key statistics

Market cap
5.42B
Enterprise value
5.49B
Trailing P/E
32.07
Forward P/E
26.71
PEG ratio
3.28
Price / sales
4.89
Price / book
4.08
EPS (TTM)
5.30
Beta
0.85
Dividend yield
0.56%
Payout ratio
18.11%
Profit margin
15.41%
Revenue (TTM)
1.11B
Revenue growth
8.60%
Free cash flow
139.50M
Total cash
66.26M
Total debt
142.44M
Return on equity
13.02%
Shares outstanding
31.88M
Short % of float
2.23%
50-day average
170.36
200-day average
169.21

Analyst view

Consensus: buy

Buy
Price target (mean) 213.50 +25.6% upside
Target (low)
175.00
Target (mean)
213.50
Target (high)
254.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Feb 19, 2027

Expected Feb 19, 2027. Consensus EPS estimate 1.47.

Earnings history

Financials — quick view

All financials
BCPC Revenue — quarterly 290.66M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
BCPC Net income — quarterly 46.73M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
BCPC EPS — quarterly 1.47
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

BCPC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 19, 2027Dec 30, 20261.41———
Oct 23, 2026Sep 30, 20261.431.57+0.14+9.79%
Jul 31, 2026Jun 30, 20261.271.40+0.13+10.24%
Apr 30, 2026Mar 31, 20261.331.25-0.08-6.02%
Feb 20, 2026Dec 31, 20251.291.31+0.02+1.55%
Oct 21, 2025Sep 30, 20251.361.35-0.01-0.74%

Upgrades / downgrades

BCPC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 23, 2026HC Wainwright & Co.mainBuyBuy
Aug 3, 2026HC Wainwright & Co.mainBuyBuy
May 4, 2026HC Wainwright & Co.mainBuyBuy
Feb 24, 2026HC Wainwright & Co.mainBuyBuy
Dec 5, 2025Rothschild & Coinit—Neutral
Oct 22, 2025HC Wainwright & Co.mainBuyBuy

About Balchem Corporation

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Sector
Basic Materials
Industry
Specialty Chemicals
Country
United States
Website
balchem.com

News

Your note

Sign in to keep a note on BCPC — it syncs with the Stock Master app.

Insider holders

BCPC insider holders
InsiderRelationLatest transactionDateShares held
BACKUS WILLIAM AOfficerStock Award(Grant)Feb 10, 20267,019
BENGTSSON CARL MARTINChief Financial OfficerStock Award(Grant)Feb 10, 202629,012
BONED FREDERICOfficerStock Award(Grant)Feb 10, 20269,419
FISCHER DAVID BDirectorStock Award(Grant)Feb 10, 20268,859
HARRIS THEODORE LChief Executive OfficerStock Award(Grant)Feb 10, 202694,402
MIYATA HATSUKIOfficerStock Award(Grant)Feb 10, 20269,232

Institution ownership

BCPC institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.62%4,964,479843.86MJun 29, 2026
Vanguard Portfolio Management LLC6.99%2,221,267377.57MJun 29, 2026
Vanguard Capital Management LLC4.55%1,445,369245.68MJun 29, 2026
State Street Corporation4.03%1,281,552217.84MJun 29, 2026
Geode Capital Management, LLC3.53%1,122,146190.74MJun 29, 2026
Conestoga Capital Advisors, LLC3.42%1,087,871184.92MJun 29, 2026

Fund ownership

BCPC fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.98%1,898,724322.75MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.21%1,018,611173.14MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.65%842,214143.16MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.32%737,004125.28MJun 29, 2026
First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers1.81%574,50097.65MSep 29, 2026
Conestoga Funds-Conestoga Small Cap Fund1.60%508,95086.51MJun 29, 2026
Advertisement